Table 2 Univariate and multivariate analysis of factors associated with transgelin expression.

Age (<60 years vs. ≥60 years)

0.4743

0.2055–1.058

0.0764

1.9132

0.6406–5.7142

0.2452

Gender (male vs. female)

1.395

0.6335–3.196

0.4297

1.7803

0.5914–5.3595

0.3050

Size of tumor (<5 cm vs. ≥5 cm)

5.606

1.784–16.15

0.0020

6.2532

1.3738–28.4632

0.0178

Lymph node status (Negative vs. Positive)

5.456

2.290–13.26

0.0001

0.2628

0.0653–1.0572

0.0599

T-primary tumor (T1 + T2 vs. T3 + T4)

8.313

2.300–27.79

0.0004

0.2402

0.0507–1.1375

0.0722

TNM stages (I–II vs. III–IV)

5.115

2.113–12.18

0.0003

1.7055

0.4182–6.9552

0.4567

Pathological grade (I vs. II–III)

4.040

1.084–14.69

0.0383

0.1439

0.0072–2.8735

0.2044